Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_assertion type Assertion NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_head.
- NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_assertion description "[These data showed that circulating Tg mRNA is not only a more sensitive marker of residual thyroid tissue or thyroid cancer than sTg, particularly in patients during T4 therapy and with positive antithyroglobulin antibodies, but also was more sensitive than NIS mRNA in all patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_provenance.
- NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_assertion evidence source_evidence_literature NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_provenance.
- NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_assertion SIO_000772 11061512 NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_provenance.
- NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_assertion wasDerivedFrom befree-2016 NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_provenance.
- NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_assertion wasGeneratedBy ECO_0000203 NP299236.RANeXp0ENcL7_U3RvQ6nPIH43M7KvbDN7tyD9MHpWNT2M130_provenance.